1. An allergic phenotype and the use of steroid inhalers predict eosinophilic oesophagitis in patients with asthma. Issue 1 (8th November 2012) Authors: Harer, K. N.; Enders, F. T.; Lim, K. G.; Alexander, J. A.; Katzka, D. A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 1(2013) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Commentary: a comparison of glucagon‐like peptides 1 and 2. Issue 2 (17th December 2012) Authors: Moran, G. W.; Lal, S.; McLaughlin, J. T. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commentary: a gastrin antagonist against carcinoids – implications for PPI‐induced hypergastrinaemia. Issue 2 (17th December 2012) Authors: McCarthy, D. M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Commentary: adherence and detection rates in colorectal cancer screening – author's reply. Issue 1 (4th December 2012) Authors: Hassan, C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 1(2013) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Commentary: adherence and detection rates in colorectal cancer screening. Issue 1 (4th December 2012) Authors: Hilmi, I.; Goh, K.‐L. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 1(2013) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Commentary: assessment of non‐alcoholic fatty liver disease using serum total cell death and apoptosis markers – authors' reply. Issue 2 (17th December 2012) Authors: Shen, J.; Wong, V. W.‐S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Commentary: assessment of non‐alcoholic fatty liver disease using serum total cell death and apoptosis markers. Issue 2 (17th December 2012) Authors: Miller, M. H.; Dillon, J. F. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome – author's reply. Issue 2 (17th December 2012) Authors: Matricon, J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Issue 2 (17th December 2012) Authors: Jovani, M.; Fiorino, G.; Danese, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 2(2013) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Commentary: detection of infliximab levels and anti‐infliximab antibodies. Issue 1 (4th December 2012) Authors: Seow, C. H.; Panaccione, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 1(2013) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗